Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06502483 · ClinicalTrials.gov registry record · NA

PRISM for Depression and Anxiety in Young Adults With Cancer

A NA study of Depression and Anxiety, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06502483: Active NA study of Depression and Anxiety, sponsored by Dana-Farber Cancer Institute.

NCT06502483 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 15 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06502483, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer or desmoid tumor may experience. The name of the intervention used in this research study is: -Promoting Resilience in Stress Management (PRISM) Program

Primary Outcome

Feasibility is defined as 70% of PRISM sessions are completed by participants who start the study.

Conditions Studied

Depression Anxiety Anxiety Disorders Depressive Disorder Depression, Anxiety Cancer Diagnosis Non-Metastatic Neoplasm Desmoid

Interventions

  • BEHAVIORAL Promoting Resilience in Stress Management Program

Study Locations (1)

Massachusetts

  • Dana-Farber Cancer Institute - Brighton

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-09-06
Est. Completion 2026-02-01
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the registry record for NCT06502483 still lists

NCT06502483 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower).

The record links to 8 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Promoting Resilience in Stress Management Program is the first listed.

NCT06502483 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06502483 about?

NCT06502483 is a clinical study titled "PRISM for Depression and Anxiety in Young Adults With Cancer". This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer or desmoid tumor may experience. The name of the intervention used in thi...

What is the current status of trial NCT06502483?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-09-06. Estimated completion is 2026-02-01.

What conditions does trial NCT06502483 study?

This clinical trial studies the following conditions: Depression, Anxiety, Anxiety Disorders, Depressive Disorder, Depression, Anxiety.

What interventions are being tested in trial NCT06502483?

The interventions under investigation include: Promoting Resilience in Stress Management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06502483?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06502483 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06502483's enrollment target sits among peer trials

15 641st of 679 higher than 33 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Related registry views

Source: ClinicalTrials.gov NCT06502483, the US trial registry maintained by the National Library of Medicine. NCT06502483 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.